{"id":"https://openalex.org/W2283343586","doi":null,"title":"Alpha-synuclein overexpression model.","display_name":"Alpha-synuclein overexpression model.","publication_year":2006,"publication_date":"2006-01-01","ids":{"openalex":"https://openalex.org/W2283343586","mag":"2283343586","pmid":"https://pubmed.ncbi.nlm.nih.gov/17017543"},"language":"en","primary_location":{"id":"pmid:17017543","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17017543","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of neural transmission. Supplementum","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044022978","display_name":"Hideki Mochizuki","orcid":"https://orcid.org/0000-0002-0874-7542","observed_orcids":["https://orcid.org/0000-0002-0874-7542"]},"institutions":[{"id":"https://openalex.org/I34077901","display_name":"Juntendo University","ror":"https://ror.org/01692sz90","country_code":"JP","type":"education","lineage":["https://openalex.org/I34077901"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"H Mochizuki","raw_affiliation_strings":["Research Institute for Diseases of Old Age, Juntendo University, Bunkyo, Tokyo, Japan. hideki@med.juntendo.ac.jp"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Institute for Diseases of Old Age, Juntendo University, Bunkyo, Tokyo, Japan. hideki@med.juntendo.ac.jp","institution_ids":["https://openalex.org/I34077901"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040438371","display_name":"Masanori YAMADA","orcid":"https://orcid.org/0000-0002-9793-8825","observed_orcids":["https://orcid.org/0000-0002-9793-8825"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Yamada","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5055474625","display_name":"Yuji Mizuno","orcid":"https://orcid.org/0000-0001-9255-9693","observed_orcids":["https://orcid.org/0000-0001-9255-9693"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y Mizuno","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.8848,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":{"value":0.7322667,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":null,"issue":"70","first_page":"281","last_page":"4"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13991","display_name":"Nuclear Receptors and Signaling","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alpha-synuclein","display_name":"alpha-synuclein","score":0.9829999804496765},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.9959999918937683},{"id":"https://openalex.org/keywords/dementia-with-lewy-bodies","display_name":"dementia with Lewy bodies","score":0.8569999933242798},{"id":"https://openalex.org/keywords/synucleinopathies","display_name":"synucleinopathies","score":0.8569999933242798},{"id":"https://openalex.org/keywords/dopaminergic-neuron-degeneration","display_name":"dopaminergic neuron loss","score":0.8700000047683716},{"id":"https://openalex.org/keywords/substantia-nigra","display_name":"substantia nigra","score":0.9980000257492065},{"id":"https://openalex.org/keywords/adeno-associated-virus-vectors","display_name":"adeno-associated virus vectors","score":0.7590000033378601},{"id":"https://openalex.org/keywords/gene-transfer","display_name":"gene transfer","score":0.8259999752044678},{"id":"https://openalex.org/keywords/caspase-9-activation","display_name":"caspase-9 activation","score":0.9279999732971191},{"id":"https://openalex.org/keywords/neurodegeneration","display_name":"neurodegeneration","score":0.8650000095367432},{"id":"https://openalex.org/keywords/parkinson-s-disease-model","display_name":"Parkinson's disease model","score":0.6389999985694885},{"id":"https://openalex.org/keywords/gene-therapy","display_name":"gene therapy","score":0.9359999895095825}],"concepts":[{"id":"https://openalex.org/C2781449126","wikidata":"https://www.wikidata.org/wiki/Q288591","display_name":"Alpha-synuclein","level":4,"score":0.841545581817627},{"id":"https://openalex.org/C2780942790","wikidata":"https://www.wikidata.org/wiki/Q372016","display_name":"Pathogenesis","level":2,"score":0.8065227270126343},{"id":"https://openalex.org/C2780938664","wikidata":"https://www.wikidata.org/wiki/Q753278","display_name":"Substantia nigra","level":4,"score":0.7896960377693176},{"id":"https://openalex.org/C2776925932","wikidata":"https://www.wikidata.org/wiki/Q1755122","display_name":"Neurodegeneration","level":3,"score":0.7315787672996521},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.6177812814712524},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.5774597525596619},{"id":"https://openalex.org/C2778548049","wikidata":"https://www.wikidata.org/wiki/Q101245788","display_name":"Dementia with Lewy bodies","level":4,"score":0.5589298605918884},{"id":"https://openalex.org/C64943373","wikidata":"https://www.wikidata.org/wiki/Q2651003","display_name":"Alpha (finance)","level":4,"score":0.5461574196815491},{"id":"https://openalex.org/C102230213","wikidata":"https://www.wikidata.org/wiki/Q430117","display_name":"Transgene","level":3,"score":0.5279535055160522},{"id":"https://openalex.org/C141035611","wikidata":"https://www.wikidata.org/wiki/Q5532934","display_name":"Genetically modified mouse","level":4,"score":0.5002787113189697},{"id":"https://openalex.org/C2777916540","wikidata":"https://www.wikidata.org/wiki/Q24767155","display_name":"Synuclein","level":5,"score":0.45725932717323303},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4243919551372528},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.35880011320114136},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.35314953327178955},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.3527725338935852},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3163061738014221},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2938944697380066},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2921827435493469},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.2266988456249237},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.21599313616752625},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.19376075267791748},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.12972360849380493},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0},{"id":"https://openalex.org/C2775944032","wikidata":"https://www.wikidata.org/wiki/Q22907659","display_name":"Patient satisfaction","level":2,"score":0.0},{"id":"https://openalex.org/C49453240","wikidata":"https://www.wikidata.org/wiki/Q1592163","display_name":"Construct validity","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000256","descriptor_name":"Adenoviridae","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001923","descriptor_name":"Brain Chemistry","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D005455","descriptor_name":"Fluorescent Antibody Technique","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005822","descriptor_name":"Genetic Vectors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009474","descriptor_name":"Neurons","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D010302","descriptor_name":"Parkinson Disease, Secondary","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D010302","descriptor_name":"Parkinson Disease, Secondary","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D010766","descriptor_name":"Phosphorylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010957","descriptor_name":"Plasmids","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D013378","descriptor_name":"Substantia Nigra","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051844","descriptor_name":"alpha-Synuclein","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D051844","descriptor_name":"alpha-Synuclein","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:17017543","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17017543","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of neural transmission. Supplementum","raw_type":"Journal Article"},{"id":"mag:2283343586","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17017543","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W154719516","https://openalex.org/W2056675110","https://openalex.org/W2101167927","https://openalex.org/W1997417422","https://openalex.org/W1811548175","https://openalex.org/W4402549922","https://openalex.org/W4296930794","https://openalex.org/W7074177125","https://openalex.org/W2024041381","https://openalex.org/W1690318953"],"abstract_inverted_index":{"OBJECTIVES:":[0],"To":[1],"elucidate":[2],"the":[3,8,42,56,60,76,107,120,185,188,200],"role":[4],"of":[5,10,22,45,62,96,110,122,127,133,153,162,187,190],"alpha-synuclein":[6,16,24,85,128,144,154],"in":[7,25,59,68,99,117,140],"pathogenesis":[9,121,189],"Parkinson's":[11],"disease":[12],"(PD),":[13],"both":[14],"human":[15,23,84],"transgenic":[17],"mice":[18],"and":[19,91,131,166,172,192],"targeted":[20],"overexpression":[21,152],"rat":[26,89],"substantia":[27],"nigra":[28],"(SN)":[29],"by":[30],"viral":[31,79],"vector-based":[32],"methods":[33],"have":[34],"been":[35],"studied,":[36],"however":[37],"little":[38],"is":[39,51,177,196],"known":[40],"about":[41],"pathogenetic":[43,57],"changes":[44,58],"dopaminergic":[46,97],"neuron":[47],"loss.":[48],"Therefore,":[49],"it":[50],"necessary":[52],"to":[53,88,179],"address":[54],"whether":[55],"brains":[61,163],"patients":[63],"with":[64,119,164,168],"PD":[65,165,191],"are":[66],"recapitulated":[67],"these":[69],"models.":[70],"METHODS":[71],"AND":[72],"RESULTS:":[73],"We":[74],"used":[75],"recombinant":[77],"adeno-associated":[78],"(rAAV)":[80],"vector":[81],"system":[82],"for":[83,184,199],"gene":[86,201],"transfer":[87],"SN":[90,100],"observed":[92],"approximately":[93],"50%":[94],"loss":[95],"neurons":[98],"at":[101,129],"13":[102],"weeks":[103],"after":[104],"infection.":[105],"In":[106],"slower":[108],"progression":[109],"neurodegeneration,":[111],"we":[112],"identified":[113],"several":[114,159],"important":[115,160],"features":[116,161],"common":[118],"PD,":[123],"such":[124],"as":[125],"phosphorylation":[126],"Ser129":[130],"activation":[132],"caspase-9.":[134],"Both":[135],"findings":[136],"were":[137],"also":[138,197],"evident":[139],"cortical":[141],"tissues":[142],"overexpressing":[143],"via":[145,155],"rAAV.":[146],"CONCLUSIONS:":[147],"Our":[148],"results":[149],"indicate":[150],"that":[151],"rAAV":[156],"apparently":[157],"recapitulates":[158],"dementia":[167],"Lewy":[169],"bodies":[170],"(DLB),":[171],"thus":[173],"alpha-synucleinopathy":[174],"described":[175],"here":[176],"likely":[178],"be":[180],"an":[181],"ideal":[182],"model":[183,195],"study":[186],"DLB.":[193],"This":[194],"useful":[198],"therapy":[202],"research.":[203]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}